Julie Bryant

Founder & CEO at Rancho BioSciences

Julie works in business development for Rancho BioSciences liaising with customers and supporting projects. Julie brings years of executive international management experience in the life sciences business: GeneGo (systems biology), Thomson Reuters (scientific content), OminiViz (text mining), Genometrix (gene expression and genotyping), and Biosym/Accelrys (molecular modeling software). She has also advised and helped fund start-ups such as: FreedomVoice, aPriori Beauty Company, Simulscribe and Bimini Pet Health. Julie has also been involved in M&A activity selling GeneGo to Thomson Reuters and more recently supporting the GoDaddy acquisition of FreedomVoice.

Julie earned her science degree in England, has edited a Pathway book and is listed on several nutritional patents. Julie is also on the advisory board for Rady Children’s Hospital, Collaborations Pharmaceuticals and the Brain Trust Committee (John Wayne Cancer Institute).

Links

Previous companies

Thomson Reuters logo

Timeline

  • Founder & CEO

    Current role

A panel showing how The Org can help with contacting the right person.